TN HB2060 | 2023-2024 | 113th General Assembly
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Republican 4-2)
Status: Passed on May 9 2024 - 100% progression
Action: 2024-05-09 - Comp. became Pub. Ch. 808
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Slight Partisan Bill (Republican 4-2)
Status: Passed on May 9 2024 - 100% progression
Action: 2024-05-09 - Comp. became Pub. Ch. 808
Text: Latest bill text (Chaptered) [PDF]
Summary
As enacted, makes changes to the law relative to prescribing buprenorphine products. - Amends TCA Title 33 and Title 53.
Title
AN ACT to amend Tennessee Code Annotated, Title 33 and Title 53, relative to the treatment of opiate addiction.
Sponsors
| Rep. Tim Hicks [R] | Rep. Mary Littleton [R] | Rep. Rebecca Alexander [R] | Rep. Esther Helton-Haynes [R] |
| Rep. Antonio Parkinson [D] | Rep. G.A. Hardaway [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-09 | Comp. became Pub. Ch. 808 | |
| 2024-04-11 | House | Sponsor(s) Added. |
| 2024-04-11 | House | Comp. SB subst. |
| 2024-04-04 | House | H. Placed on Regular Calendar for 4/11/2024 |
| 2024-04-03 | House | Placed on cal. Calendar & Rules Committee for 4/4/2024 |
| 2024-03-27 | House | Rec. for pass. if am., ref. to Calendar & Rules Committee |
| 2024-03-20 | House | Placed on cal. Health Committee for 3/27/2024 |
| 2024-03-20 | House | Rec for pass if am by s/c ref. to Health Committee |
| 2024-03-13 | House | Placed on s/c cal Health Subcommittee for 3/19/2024 |
| 2024-03-12 | House | Action Def. in s/c Health Subcommittee to 3/19/2024 |
| 2024-03-06 | House | Placed on s/c cal Health Subcommittee for 3/12/2024 |
| 2024-01-30 | House | Assigned to s/c Health Subcommittee |
| 2024-01-29 | House | P2C, ref. to Health Committee |
| 2024-01-25 | House | Intro., P1C. |
| 2024-01-24 | House | Filed for introduction |
Same As/Similar To
SB2019 (Crossfiled) 2024-05-09 - Effective date(s) 07/01/2024
